CROSSLINKED FLUORESCENT LATEXES

Methods of making a crosslinked fluorescent latex are provided. In an embodiment, such a method comprises adding a water-soluble initiator to an uncrosslinked fluorescent latex comprising water and uncrosslinked resin particles comprising an unsaturated resin and a fluorescent agent incorporated therein; and exposing the water-soluble initiator to conditions to activate the water-soluble initiator and induce crosslinking reactions between the activated water-soluble initiator and the unsaturated resin, thereby forming a crosslinked fluorescent latex comprising crosslinked fluorescent resin particles comprising crosslinked resin and the fluorescent agent incorporated therein. Crosslinked fluorescent latexes are also provided, as are fluorescent toners made from the same. 1. A method of making a crosslinked fluorescent latex , the method comprising:adding a water-soluble initiator to an uncrosslinked fluorescent latex comprising water and uncrosslinked resin particles comprising an unsaturated resin and a fluorescent agent incorporated therein; andexposing the water-soluble initiator to conditions to activate the water-soluble initiator and induce crosslinking reactions between the activated water-soluble initiator and the unsaturated resin, thereby forming a crosslinked fluorescent latex comprising crosslinked fluorescent resin particles comprising crosslinked resin and the fluorescent agent incorporated therein.2. The method of claim 1 , wherein the crosslinked fluorescent latex is characterized by a degree of crosslinking n of no more than 0.50 over range of frequencies from 0.100 to 1.000 rad/s as determined from a rheology sweep test at 120° C.3. The method of claim 1 , wherein the degree of crosslinking n is no more than 0.10.4. The method of claim 1 , wherein the crosslinked fluorescent latex is characterized by a peak reflectance value that is within ±2% of a peak reflectance value of the uncrosslinked fluorescent latex.5. The method of claim 1 , wherein the ...

FLUORESCENT PINK TONERS AND RELATED METHODS

Methods of making fluorescent pink toners are provided which comprise forming one or more fluorescent latexes which comprise a red fluorescent agent, a yellow fluorescent agent, a first type of amorphous resin, and a second type of amorphous resin, wherein the first and second types of amorphous resins are present at a ratio in a range of from 2:3 to 3:2; forming a mixture comprising the one or more fluorescent latexes; one or more emulsions which comprise a crystalline resin, the first type of amorphous resin, the second type of amorphous resin; and optionally, a wax dispersion; aggregating the mixture to form particles of a predetermined size; forming a shell over the particles of the predetermined size to form core-shell particles; and coalescing the core-shell particles to form a fluorescent pink toner. Fluorescent pink toners and methods of using such toners are also provided. 1. A method of making a fluorescent pink toner , the method comprising:forming one or more fluorescent latexes which comprise a red fluorescent agent, a yellow fluorescent agent, a first type of amorphous resin, and a second type of amorphous resin, wherein the first and second types of amorphous resins are present at a ratio in a range of from 2:3 to 3:2;forming a mixture comprising the one or more fluorescent latexes; one or more emulsions which comprise a crystalline resin, the first type of amorphous resin, the second type of amorphous resin; and optionally, a wax dispersion;aggregating the mixture to form particles of a predetermined size;forming a shell over the particles of the predetermined size to form core-shell particles; andcoalescing the core-shell particles to form a fluorescent pink toner.2. The method of claim 1 , wherein the first and second types of amorphous resins are present in the one or more fluorescent latexes at 1:1.3. The method of claim 1 , wherein the red and yellow fluorescent agents together are present in the one or more fluorescent latexes in a range of ...

Fluorescent white toners and related methods

Methods of making a fluorescent white toner are provided. In embodiments, such a method comprises forming one or more fluorescent latexes which comprise a fluorescent agent, a first type of amorphous resin, and a second type of amorphous resin, wherein the first and second types of amorphous resins are present at a ratio in a range of from 2:3 to 3:2; forming a mixture comprising the one or more fluorescent latexes; a dispersion comprising a white colorant and a surfactant; one or more emulsions which comprise a crystalline resin, the first type of amorphous resin, the second type of amorphous resin; and optionally, a wax dispersion; aggregating the mixture to form particles of a predetermined size; forming a shell over the particles of the predetermined size to form core-shell particles; and coalescing the core-shell particles to form a fluorescent white toner. The fluorescent white toners and methods of using such toners are also provided.

Fluorescent magenta latex with enhanced brightness and toners made therefrom

Fluorescent magenta latexes are provided which may comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent magenta latex has a weight ratio of the Solvent Red 49 to the Solvent Yellow 98 in a range of from 3:1 to 10:1. Fluorescent magenta toners and methods of making and using the fluorescent magenta toners are also provided.

FLUORESCENT ORANGE LATEX WITH ENHANCED BRIGHTNESS AND TONERS MADE THEREFROM

Fluorescent orange latexes are provided which comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent orange latex has a weight ratio of the Solvent Yellow 98 to the Solvent Red 49 in a range of from 20:1 to 0.5:1. Fluorescent orange toners and methods of making and using the fluorescent orange toners are also provided. 1. A fluorescent orange latex comprising water and fluorescent agent-incorporated resin particles , the particles comprising a resin , Solvent Red 49 as a red fluorescent agent , and Solvent Yellow 98 as a yellow fluorescent agent , wherein the fluorescent orange latex has a weight ratio of the Solvent Yellow 98 to the Solvent Red 49 in a range of from 20:1 to 0.5:1.2. The fluorescent orange latex of claim 1 , wherein the fluorescent orange latex exhibits Förster Resonance Energy Transfer (FRET) under illumination with light having a wavelength to excite the yellow fluorescent agent.3. The fluorescent orange latex of claim 1 , further comprising a fluorescent brightener having a fluorescence emission spectrum that overlaps with an absorption spectrum of the yellow fluorescent agent.4. The fluorescent orange latex of claim 3 , wherein the fluorescent orange latex exhibits FRET under illumination with ultraviolet light.5. The fluorescent orange latex of claim 3 , wherein the fluorescence emission spectrum of the fluorescent brightener and the absorption spectrum of the yellow fluorescent agent have a degree of overlap of from 30% to 100%.6. The fluorescent orange latex of claim 1 , wherein the fluorescent brightener is Fluorescent Brightener 184.7. The fluorescent orange latex of claim 3 , having a total amount of the red fluorescent agent claim 3 , the yellow fluorescent agent claim 3 , and the fluorescent brightener in a range of from 0.5 weight % to 5 weight % by weight of the ...

FLUORESCENT METALLIC TONERS AND RELATED METHODS

Methods of making fluorescent metallic toners are provided which comprise forming one or more fluorescent latexes which comprise a fluorescent agent, a first type of amorphous resin, and a second type of amorphous resin, wherein the first and second types of amorphous resins are present at a ratio in a range of from 2:3 to 3:2; forming a mixture comprising the one or more fluorescent latexes; a dispersion comprising aluminum flakes and a surfactant; one or more emulsions which comprise a crystalline resin, the first type of amorphous resin, the second type of amorphous resin; and optionally, a wax dispersion; aggregating the mixture to form particles of a predetermined size; forming a shell over the particles of the predetermined size to form core-shell particles; and coalescing the core-shell particles to form a fluorescent metallic toner. Fluorescent metallic toners and methods of using such toners are also provided. 1. A method of making a fluorescent metallic toner , the method comprising:forming one or more fluorescent latexes which comprise a fluorescent agent, a first type of amorphous resin, and a second type of amorphous resin, wherein the first and second types of amorphous resins are present at a ratio in a range of from 2:3 to 3:2;forming a mixture comprising the one or more fluorescent latexes; a dispersion comprising aluminum flakes and a surfactant; one or more emulsions which comprise a crystalline resin, the first type of amorphous resin, the second type of amorphous resin; and optionally, a wax dispersion;aggregating the mixture to form particles of a predetermined size;forming a shell over the particles of the predetermined size to form core-shell particles; andcoalescing the core-shell particles to form a fluorescent metallic toner.2. The method of claim 1 , wherein the first and second types of amorphous resins are present in the one or more fluorescent latexes at 1:1.3. The method of claim 1 , wherein the fluorescent agent is present in the ...

FLUORESCENT MAGENTA LATEX WITH ENHANCED BRIGHTNESS AND TONERS MADE THEREFROM

Fluorescent magenta latexes are provided which may comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent magenta latex has a weight ratio of the Solvent Red 49 to the Solvent Yellow 98 in a range of from 3:1 to 10:1. Fluorescent magenta toners and methods of making and using the fluorescent magenta toners are also provided. 1. A fluorescent magenta toner comprising toner particles , the toner particles comprising fluorescent agent-incorporated resin particles comprising a resin , Solvent Red 49 as a red fluorescent agent , Solvent Yellow 98 as a yellow fluorescent agent , and a fluorescent brightener having a fluorescence emission spectrum that overlaps with an absorption spectrum of the yellow fluorescent agent , wherein the fluorescent agent-incorporated resin particles have a weight ratio of the Solvent Red 49 to the Solvent Yellow 98 in a range of from 3:1 to 10:1 , and wherein the fluorescent magenta toner exhibits Förster Resonance Energy Transfer (FRET) under illumination with light having a wavelength to excite the yellow fluorescent agent and FRET under illumination with ultraviolet light.2. The fluorescent magenta toner of claim 1 , wherein the fluorescence emission spectrum of the fluorescent brightener and the absorption spectrum of the yellow fluorescent agent have a degree of overlap of from 30% to 100%.3. The fluorescent magenta toner of claim 1 , wherein the fluorescent brightener is Fluorescent Brightener 184.4. The fluorescent magenta toner of claim 1 , having a total amount of the red fluorescent agent claim 1 , the yellow fluorescent agent claim 1 , and the fluorescent brightener in a range of from 0.5 weight % to 5 weight % by weight of the toner and a weight ratio of the fluorescent brightener to the red and yellow fluorescent agents in a range of from 1:10 to 1:0.5.5. The ...

Fluorescent white toners and related methods

Methods of making a fluorescent white toner are provided. In embodiments, such a method comprises forming one or more fluorescent latexes which comprise a fluorescent agent, a first type of amorphous resin, and a second type of amorphous resin, wherein the first and second types of amorphous resins are present at a ratio in a range of from 2:3 to 3:2; forming a mixture comprising the one or more fluorescent latexes; a dispersion comprising a white colorant and a surfactant; one or more emulsions which comprise a crystalline resin, the first type of amorphous resin, the second type of amorphous resin; and optionally, a wax dispersion; aggregating the mixture to form particles of a predetermined size; forming a shell over the particles of the predetermined size to form core-shell particles; and coalescing the core-shell particles to form a fluorescent white toner. The fluorescent white toners and methods of using such toners are also provided.

Fluorescent metallic toners and related methods

Methods of making fluorescent metallic toners are provided which comprise forming one or more fluorescent latexes which comprise a fluorescent agent, a first type of amorphous resin, and a second type of amorphous resin, wherein the first and second types of amorphous resins are present at a ratio in a range of from 2:3 to 3:2; forming a mixture comprising the one or more fluorescent latexes; a dispersion comprising aluminum flakes and a surfactant; one or more emulsions which comprise a crystalline resin, the first type of amorphous resin, the second type of amorphous resin; and optionally, a wax dispersion; aggregating the mixture to form particles of a predetermined size; forming a shell over the particles of the predetermined size to form core-shell particles; and coalescing the core-shell particles to form a fluorescent metallic toner. Fluorescent metallic toners and methods of using such toners are also provided.

Fluorescent orange latex with enhanced brightness and toners made therefrom

Fluorescent orange latexes are provided which comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent orange latex has a weight ratio of the Solvent Yellow 98 to the Solvent Red 49 in a range of from 20:1 to 0.5:1. Fluorescent orange toners and methods of making and using the fluorescent orange toners are also provided.

Fused heterocyclic derivatives and their use in the treatment of hbv infection

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Fluorescent magenta latex with enhanced brightness and toners made therefrom

Fluorescent magenta latexes are provided which may comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent magenta latex has a weight ratio of the Solvent Red 49 to the Solvent Yellow 98 in a range of from 3:1 to 10:1. Fluorescent magenta toners and methods of making and using the fluorescent magenta toners are also provided.

Fluorescent magenta latex with enhanced brightness and toners made therefrom

Fluorescent magenta latexes are provided which may comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent magenta latex has a weight ratio of the Solvent Red 49 to the Solvent Yellow 98 in a range of from 3:1 to 10:1. Fluorescent magenta toners and methods of making and using the fluorescent magenta toners are also provided.

Fluorescent orange latex with enhanced brightness and toners made therefrom

Fluorescent orange latexes are provided which comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent orange latex has a weight ratio of the Solvent Yellow 98 to the Solvent Red 49 in a range of from 20:1 to 0.5:1. Fluorescent orange toners and methods of making and using the fluorescent orange toners are also provided.

Fluorescent latexes with enhanced brightness

Fluorescent latexes are provided. In embodiments, a fluorescent latex comprises water and fluorescent agent-incorporated resin particles, the particles comprising a resin and a Förster Resonance Energy Transfer (FRET) pair comprising a fluorescent brightener having a fluorescence emission spectrum and a fluorescent dye having an absorption spectrum that overlaps with the fluorescence emission spectrum of the fluorescent brightener, wherein the fluorescent latex exhibits FRET under illumination with ultraviolet (UV) light. Fluorescent toners made from the fluorescent latexes are provided. Methods of making and using the fluorescent toners are also provided.

Fused heterocyclic derivatives and their use in the treatment of hbv infection

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

３ｄ印刷物のｚ軸強度を向上させるための磁性粒子の利用

【課題】３Ｄ印刷物のｚ軸強度を向上させるための方法を提供する。【解決手段】ポリマー及び磁性粒子を用いて３次元（３Ｄ）オブジェクトを印加することと、３Ｄオブジェクトをポリマーのほぼ融解温度の温度に加熱することと、３Ｄオブジェクトに磁場を印加して、ポリマー中の磁性粒子を局所的に運動させて熱を発生させ、磁性粒子の周囲でポリマーを融合させて、３Ｄオブジェクトのｚ軸強度を向上させることと、を含む方法である。【選択図】図１

Fused heterocyclic derivatives

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Derivados heterocíclicos condensados

La solicitud describe compuestos que son derivados heterocíclicos condensados, composiciones farmacéuticas que comprenden estos compuestos, procesos químicos para preparar estos compuestos y su uso en el tratamiento de enfermedades asociadas con una infección por VHB. Reivindicación 1: Un compuesto de fórmula (1), o una forma estereoisomérica o tautomérica de este, en donde: R¹ se selecciona del grupo que consiste en fenilo, heteroarilo de 5 miembros y heteroarilo de 6 miembros, cada uno de los cuales está sustituido por 1, 2 o 3 sustituyentes, estando cada uno de dichos sustituyentes seleccionado independientemente del grupo que consiste en halo, alquilo C₁₋₆, cicloalquilo C₃₋₆, CN, CF₃, CHF₂, OCHF₂ y OCF₃; R² se selecciona del grupo que consiste en H, CHF₂, CF₃, alquilo C₁₋₆, (alquil C₁₋₆)O(alquilo C₁₋₆) y cicloalquilo C₃₋₆; Q representa un anillo seleccionado del grupo que consiste en fenilo, heteroarilo de 5 miembros y heteroarilo de 6 miembros; n representa 0, 1, 2 o 3; cada R³ representa independientemente un sustituyente seleccionado del grupo que consiste en CN, alquilo C₁₋₆, alcoxilo C₁₋₆, cicloalquilo C₃₋₆, heteroarilo de 5 miembros, heteroarilo de 6 miembros, heterociclilo de 4 - 8 miembros, halo, N(RS)₂, S(O)RS y S(O)₂RS, cada uno del alquilo C₁₋₆, alcoxilo C₁₋₆, cicloalquilo C₃₋₆, heteroarilo de 5 miembros, heteroarilo de 6 miembros, heterociclilo de 4 - 8 miembros, N(RS)₂, S(O)RS y S(O)₂RS está sustituido opcionalmente con 1, 2, 3, 4 o 5 sustituyentes, seleccionado cada uno de dichos sustituyentes independientemente del grupo que consiste en halo, hidroxilo, alquilo C₁₋₆ y oxo; RS se selecciona cada uno independientemente del grupo que consiste en H, alquilo C₁₋₆, alcoxilo C₁₋₆ y cicloalquilo C₃₋₆; Rˣ y Rʸ se seleccionan cada uno independientemente del grupo que consiste en hidrógeno, alquilo C₁₋₆ y cicloalquilo C₃₋₆; en donde se excluyen los siguientes compuestos: del grupo de fórmulas (2); o una sal o un solvato farmacéuticamente aceptable de este.

Fluorescent orange latex with enhanced brightness and toners made therefrom

Fluorescent orange latexes are provided which comprise water and fluorescent agent-incorporated resin particles, the particles comprising a resin, Solvent Red 49 as a red fluorescent agent, and Solvent Yellow 98 as a yellow fluorescent agent, wherein the fluorescent orange latex has a weight ratio of the Solvent Yellow 98 to the Solvent Red 49 in a range of from 20:1 to 0.5:1. Fluorescent orange toners and methods of making and using the fluorescent orange toners are also provided.

Fused heterocyclic derivatives

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Mll1 inhibitors and anti-cancer agents

Derivados heterocíclicos condensados

Reivindicación 1: Un compuesto de fórmula (1), o una forma estereoisomérica o tautomérica de este, donde: R¹ se selecciona del grupo que consiste en fenilo, piridilo, pirimidinilo, piridazinilo y pirazinilo, cada uno de los cuales está sustituido con 1, 2 ó 3 sustituyentes, seleccionándose cada uno de dichos sustituyentes independientemente del grupo que consiste en halo, alquilo C₁₋₄, cicloalquilo C₃₋₆, CN, CF₃, CHF₂, OCHF₂ y OCF₃; R² es hidrógeno o un sustituyente seleccionado del grupo que consiste en CHF₂, CF₃, alquilo C₁₋₄, (alquil C₁₋₄)O(alquilo C₁₋₄) y cicloalquilo C₃₋₆; Q representa un anillo seleccionado del grupo que consiste en fenilo, un anillo heterocíclico aromático de cinco miembros y un anillo heterocíclico aromático de seis miembros; n representa 1, 2 ó 3; cada R³ representa independientemente un sustituyente seleccionado del grupo que consiste en CF₃, CHF₂, CH₂F, alquilo C₁₋₆, O-alquilo C₁₋₆, OCF₃, OCHF₂ y cicloalquilo C₃₋₆; en el evento de que n represente 2 ó 3, dos R³ en átomos anulares adyacentes, junto con dichos átomos anulares, forman opcionalmente un anillo de 5 miembros o un anillo de 6 miembros, comprendiendo opcionalmente dicho anillo 1, 2 ó 3 heteroátomos seleccionados cada uno independientemente entre N, O y S, conteniendo opcionalmente dicho anillo uno o más sustituyentes fluoro u oxo; W es CHR⁴ y X es CHR⁵, donde R⁴ y R⁵ se seleccionan cada uno independientemente del grupo que consiste en hidrógeno, CONR⁶R⁷; fenilo; heterociclilo de 5 miembros; heterociclilo de 6 miembros; heteroarilo de 5 miembros; heteroarilo de 6 miembros; cicloalquilo C₃₋₆; alquilo C₁₋₄; y alquilo C₁₋₄ sustituido con OH, O-alquilo C₁₋₄, halo, COOH, CONR⁸R⁹, NHCO(alquilo C₁₋₄), NHCO(cicloalquilo C₃₋₆), heteroarilo de 5 miembros, heteroarilo de 6 miembros, SO₂NHalquilo C₁₋₄, SO₂NHcicloalquilo C₃₋₆, NHSO₂alquilo C₁₋₄ o NHSO₂cicloalquilo C₃₋₆; donde R⁴ y R⁵ no son ambos hidrógeno; R⁶ y R⁷ se seleccionan cada uno independientemente entre hidrógeno, cicloalquilo C₃₋₆, ...

Utilization of magnetic particles to improve z-axis strength of 3d printed objects

A method for improving z-axis strength of a 3D printed object is disclosed. For example, the method includes printing a three-dimensional (3D) object with a polymer and magnetic particles, heating the 3D object to a temperature at approximately a melting temperature of the polymer, and applying a magnetic field to the 3D object to locally move the magnetic particles in the polymer to generate heat and fuse the polymer around the magnetic particles to improve a z-axis strength of the 3D object.

Utilization of magnetic particles to improve z-axis strength of 3d printed objects

A method for improving z-axis strength of a 3D printed object is disclosed. For example, the method includes printing a three-dimensional (3D) object with a polymer and magnetic particles, heating the 3D object to a temperature at approximately a melting temperature of the polymer, and applying a magnetic field to the 3D object to locally move the magnetic particles in the polymer to generate heat and fuse the polymer around the magnetic particles to improve a z-axis strength of the 3D object.

Utilization of magnetic particles to improve z-axis strength of 3d printed objects

A method for improving z-axis strength of a 3D printed object is disclosed. For example, the method includes printing a three-dimensional (3D) object with a polymer and magnetic particles, heating the 3D object to a temperature at approximately a melting temperature of the polymer, and applying a magnetic field to the 3D object to locally move the magnetic particles in the polymer to generate heat and fuse the polymer around the magnetic particles to improve a z-axis strength of the 3D object.

Utilization of magnetic particles to improve z-axis strength of 3d printed objects

A method for improving z-axis strength of a 3D printed object is disclosed. For example, the method includes printing a three-dimensional (3D) object with a polymer and magnetic particles, heating the 3D object to a temperature at approximately a melting temperature of the polymer, and applying a magnetic field to the 3D object to locally move the magnetic particles in the polymer to generate heat and fuse the polymer around the magnetic particles to improve a z-axis strength of the 3D object.

Utilization of magnetic particles to improve z-axis strength of 3D printed objects

A method for improving z-axis strength of a 3D printed object is disclosed. For example, the method includes printing a three-dimensional (3D) object with a polymer and magnetic particles, heating the 3D object to a temperature at approximately a melting temperature of the polymer, and applying a magnetic field to the 3D object to locally move the magnetic particles in the polymer to generate heat and fuse the polymer around the magnetic particles to improve a z-axis strength of the 3D object.

Utilization of magnetic particles to improve z-axis strength of 3d printed objects

A method for improving z-axis strength of a 3D printed object is disclosed. For example, the method includes printing a three-dimensional (3D) object with a polymer and magnetic particles, heating the 3D object to a temperature at approximately a melting temperature of the polymer, and applying a magnetic field to the 3D object to locally move the magnetic particles in the polymer to generate heat and fuse the polymer around the magnetic particles to improve a z-axis strength of the 3D object.

Utilization of magnetic particles to improve z-axis strength of 3d printed objects

Fused heterocyclic derivatives

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Fused heterocyclic derivatives

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Fused heterocyclic derivatives and their use in the treatment of hbv infection

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Cable en espiral de doble revestimiento

Un cable espiral de doble revestimiento, que comprende un núcleo de cable formado mediante el trenzado de una pluralidad de núcleos de alambre, en donde el núcleo de cable se cubre con una capa de cinta de enrollado, un revestimiento interno y un revestimiento externo en secuencia, en donde un material del revestimiento interno es poliuretano de poliéster, y un material del revestimiento externo es poliuretano de poliéster.

架橋蛍光ラテックス

【課題】高度に架橋された、非常に明るい蛍光ラテックス、及び印刷中に定着機ロール部材を汚さない、電子写真式印刷システムで使用するためのトナー、並びにそれらを製造する方法を提供する。【解決手段】架橋蛍光ラテックスを作製する方法は、水と、不飽和樹脂及び組み込まれた蛍光剤を含む未架橋樹脂粒子と、を含む未架橋蛍光ラテックスに水溶性開始剤を添加することと、水溶性開始剤を活性化させ、活性化した水溶性開始剤と不飽和樹脂との間での架橋反応を誘発し、それによって架橋樹脂及び組み込まれた蛍光剤を含む架橋蛍光樹脂粒子を含む、架橋蛍光ラテックスを形成する条件に水溶性開始剤を曝露することと、を含む。架橋蛍光ラテックス、それから作製された蛍光トナーも提供される。【選択図】なし

蛍光ピンクトナー及び関連方法

【課題】蛍光ピンクトナーの製造方法を提供する。【解決手段】赤色蛍光剤、黄色蛍光剤、第１の種類の非晶質樹脂、及び第２の種類の非晶質樹脂を含む１種以上の蛍光ラテックスを形成することであって、第１の種類の非晶質樹脂及び第２の種類の非晶質樹脂は、２：３〜３：２の範囲の比率で存在する、ことと、１種以上の蛍光ラテックスと、結晶性樹脂、前記第１の種類の非晶質樹脂、前記第２の種類の非晶質樹脂、及び任意選択的にワックス分散体を含む１種以上のエマルションとを含む混合物を形成することと、混合物を凝集させて、所定のサイズの粒子を形成することと、所定のサイズの粒子の上方にシェルを形成してコア−シェル粒子を形成することと、コア−シェル粒子を合体させて蛍光ピンクトナーを形成することと、を含む。蛍光ピンクトナー及びかかるトナーの使用方法も提供する。【選択図】なし

MLL1-inhibitorer og anticancermidler

Heterocyclic glp-1 agonists

The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.

Cable en espiral de doble revestimiento

輝度が向上した蛍光緑色トナー

【課題】蛍光緑色トナーを提供する。【解決手段】実施形態では、蛍光緑色トナーは、樹脂、蛍光増白剤、及び蛍光増白剤の蛍光放出スペクトルと重なる吸収スペクトルを有する黄色蛍光剤を含む、蛍光剤が組み込まれた樹脂粒子と、シアン着色剤、樹脂及び青色染料を含む青色染料が組み込まれた樹脂粒子、又はそれらの両方と、を含む。蛍光緑色トナーは、シアン着色剤に対する黄色蛍光剤の重量比を有し、存在する場合、青色染料は１００：１〜０．２：１の範囲であり、蛍光緑色トナーは、ＵＶ光での照明下でフェルスター共鳴エネルギー移動（ＦＲＥＴ）を呈する。蛍光緑色トナーの作製方法及び使用方法も提供される。【選択図】図１

Heterocyclic glp-1 agonists

The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.

Mll1 inhibitors and anti-cancer agents

Heterocyclic glp-1 agonists

The present disclosure relates generally to glucagon-like peptide-1 (GLP-1) agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.

Fused heterocyclic derivatives

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Fused heterocyclic derivatives

The application describes fused heterocycle derivative compounds, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases associated with HBV infection.

Heterocyclic glp-1 agonists

The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.

Toner process comprising synthesizing amphiphilic block copolymers via emulsion polymerization

A toner process comprising (a) providing at least one amphiphilic block copolymer prepared by surfactant-free emulsion polymerization comprising: dissolving a hydrophilic monomer in water; adding a hydrophobic monomer; adding a feed initiator to produce a colloidal dispersion of amphiphilic block copolymer; and optionally, discharging the amphiphilic block copolymer; (b) contacting one or more of a latex polymer, a wax; and a colorant with the colloidal dispersion of amphiphilic block copolymer to form a blend; or contacting the discharged amphiphilic block copolymer with one or more of a latex polymer, a wax dispersion, and a colorant dispersion, and forming a further dispersion; (c) heating the blend or further dispersion at a temperature below the glass transition temperature of the latex polymer to form aggregated toner particles; (d) adding a coalescing agent to the toner particles thereby coalescing the toner particles; and (e) recovering the toner particles.